Marc Olivier Perret, Director, 10% Owner at Conatus Pharmaceuticals Inc (CNAT), bought 228,942 shares at $11.00 ($2.0M) on 2013-07-30, disclosed to the SEC on 2013-08-01.
Open-market purchase of $2.0M CNAT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 46,675 | $0 | 0.0% |
| 2 | $11.00 | 16,742 | $184K | 9.2% |
| 3 | $11.00 | 165,525 | $1.8M | 90.8% |
| Total | $8.76 avg | 228,942 | $2.0M | 100% |